Hart R. PCOS and infertility. Panminerva Med. 2008;50(4):305–14.

CAS  PubMed  Google Scholar 

Ehrmann DA, et al. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care. 1999;22(1):141–6.

Article  CAS  PubMed  Google Scholar 

Marchesan LB, Spritzer PM. ACC/AHA 2017 definition of high blood pressure: implications for women with polycystic ovary syndrome. Fertil Steril. 2019;111(3):579–e5871.

Article  PubMed  Google Scholar 

Kolhe JV et al. PCOS and Depression: Common Links and Potential Targets. Reprod Sci, 2021.

Cooney LG, Dokras A. Depression and anxiety in polycystic ovary syndrome: etiology and treatment. Curr Psychiatry Rep. 2017;19(11):83.

Article  PubMed  Google Scholar 

Franik G, et al. Sleep disturbances in women with polycystic ovary syndrome. Gynecol Endocrinol. 2016;32(12):1014–7.

Article  PubMed  Google Scholar 

Xu Y, Qiao J. Association of Insulin Resistance and elevated androgen levels with polycystic ovarian syndrome (PCOS): a review of literature. J Healthc Eng. 2022;2022:p9240569.

Article  Google Scholar 

Rosmond R. Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinology. 2005;30(1):1–10.

Article  CAS  PubMed  Google Scholar 

Camili FE et al. Oncostatin M is related to polycystic ovary syndrome-case control study. Biomedicines, 2024. 12(2).

Herman JP, et al. Regulation of the hypothalamic-pituitary-adrenocortical stress response. Compr Physiol. 2016;6(2):603–21.

Article  PubMed  PubMed Central  Google Scholar 

Diamanti-Kandarakis E, Economou F. Stress in women: metabolic syndrome and polycystic ovary syndrome. Ann N Y Acad Sci. 2006;1083:54–62.

Article  CAS  PubMed  Google Scholar 

Gonzalez F. Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids. 2012;77(4):300–5.

Article  CAS  PubMed  Google Scholar 

Tokmak A, et al. Effect of obesity on clinical parameters and pregnancy rates in women with polycystic ovary syndrome undergoing ovulation induction cycles. J Reprod Med. 2017;62(5–6):300–4.

PubMed  Google Scholar 

Guney G, et al. The role of ERK-1 and ERK-2 gene polymorphisms in PCOS pathogenesis. Reprod Biol Endocrinol. 2022;20(1):95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amin M, et al. Comorbidity of Novel CRHR2 gene variants in type 2 diabetes and depression. Int J Mol Sci. 2022;23(17):9819.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gragnoli C. Hypothesis of the neuroendocrine cortisol pathway gene role in the comorbidity of depression, type 2 diabetes, and metabolic syndrome. Appl Clin Genet. 2014;7:43–53.

Article  PubMed  PubMed Central  Google Scholar 

Amin M et al. Implication of Melanocortin Receptor Genes in the familial comorbidity of type 2 diabetes and depression. Int J Mol Sci, 2022;23(15).

Amin M et al. Familial linkage and association of the NR3C1 gene with type 2 diabetes and Depression Comorbidity. Int J Mol Sci, 2022;23(19).

Amin M et al. Novel linkage and association of the mineralocorticoid receptor gene (NR3C2) with familial type 2 diabetes and depression and their comorbidity. Aspects Mol Med, 2023;1.

Girardet C, Butler AA. Neural melanocortin receptors in obesity and related metabolic disorders. Biochim Biophys Acta. 2014;1842(3):482–482.

Article  CAS  PubMed  Google Scholar 

Ayers KL, et al. Melanocortin 4 receptor pathway dysfunction in obesity: patient stratification aimed at MC4R agonist treatment. J Clin Endocrinol Metab. 2018;103(7):2601–12.

Article  PubMed  PubMed Central  Google Scholar 

Srisai D, et al. Characterization of the Hyperphagic response to Dietary Fat in the MC4R knockout mouse. Endocrinology. 2011;152(3):890–890.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ji LQ, Hong Y, Tao YX. Melanocortin-5 receptor: Pharmacology and its regulation of Energy Metabolism. Int J Mol Sci, 2022;23(15).

Novoselova TV, Chan LF, Clark AJL. Pathophysiology of melanocortin receptors and their accessory proteins. Best practice & research. Clinical endocrinology & metabolism; 2018;32(2)93–106.

Healy E. Melanocortin 1 receptor variants, pigmentation, and skin cancer susceptibility. Photodermatol Photoimmunol Photomed. 2004;20(6):283–8.

Article  CAS  PubMed  Google Scholar 

Mun Y, Kim W, Shin D. Melanocortin 1 receptor (MC1R): pharmacological and therapeutic aspects. Int J Mol Sci, 2023;24(15).

Gerhard GS, et al. Next-generation sequence analysis of genes associated with obesity and nonalcoholic fatty liver disease-related cirrhosis in extreme obesity. Human Hered. 2013;75(2–4):144–51.

Article  CAS  Google Scholar 

Nooranizadeh MH, et al. Enhancement of Melanocortin-4 receptor (MC4R) and constancy of Kiss1 mRNAs expression in the Hypothalamic Arcuate Nucleus in a model of polycystic ovary syndrome rat. Galen Med J. 2018;7:e1070.

Article  PubMed  PubMed Central  Google Scholar 

Hepsen S, et al. Melanocortin 3 receptor gene polymorphism is associated with polycystic ovary syndrome in Turkish population. Gynecol Endocrinol. 2019;35(8):685–90.

Article  CAS  PubMed  Google Scholar 

Yuan H, et al. Interaction between common variants of FTO and MC4R is associated with risk of PCOS. Reprod Biol Endocrinol. 2015;13:55.

Article  PubMed  PubMed Central  Google Scholar 

Yu K, et al. Association between MC4R rs17782313 genotype and obesity: a meta-analysis. Gene. 2020;733:144372.

Article  CAS  PubMed  Google Scholar 

Legro RS. Obesity and PCOS: implications for diagnosis and treatment. Semin Reprod Med. 2012;30(6):496–506.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sull JW, Kim G, Jee SH. Association of MC4R (rs17782313) with diabetes and cardiovascular disease in Korean men and women. BMC Med Genet. 2020;21(1):160.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roldan Martin MB, et al. Mutational analysis of the melanocortin-4 receptor (MC4R) gene in children with premature pubarche and adolescent girls with hyperandrogenism. Fertil Steril. 2004;82(5):1460–2.

Article  CAS  PubMed  Google Scholar 

Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018;182:27–36.

Article  CAS  PubMed  Google Scholar 

Morgan DA, et al. Regulation of glucose tolerance and sympathetic activity by MC4R signaling in the lateral hypothalamus. Diabetes. 2015;64(6):1976–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Metzger PJ et al. A human obesity-associated MC4R mutation with defective Gq/11α signaling leads to hyperphagia in mice. J Clin Invest, 2024;134(4).

Rotterdam EA. .-S.P.c.w.g., revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–7.

Article  Google Scholar 

Purcell S, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hiekkalinna T, et al. PSEUDOMARKER: a powerful program for joint linkage and/or linkage disequilibrium analysis on mixtures of singletons and related individuals. Hum Hered. 2011;71(4):256–66.

Article  PubMed  PubMed Central  Google Scholar 

Kumar S, Ambrosini G, Bucher P. SNP2TFBS - a database of regulatory SNPs affecting predicted transcription factor binding site affinity. Nucleic Acids Res. 2017;45(D1):D139–44.